A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Sep, 23 2025
Mar, 22 2025
Apr, 9 2026
Nov, 25 2025
Feb, 9 2026